Showing 1,121 - 1,140 results of 31,940 for search '(( 50 ((a decrease) OR (mean decrease)) ) OR ( 5 ((fold decrease) OR (nn decrease)) ))', query time: 0.86s Refine Results
  1. 1121

    SPL treatment decreases diabetes-induced decrement in protein expression of cldn-5 in glomeruli (GL) and cldn-2 and occldn in proximal tubules (PT). by Eduardo Molina-Jijón (4020464)

    Published 2017
    “…<p>SPL prevents diabetes-induced decrease of cldn-5 protein expression (A and B) in GL, and mRNA (F) and protein expression of cldn-2 (A and C), and protein expression of occldn (A and D) in PT (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0177362#pone.0177362.s002" target="_blank">S2 Fig</a>). …”
  2. 1122

    Longer <i>L</i><sub><i>h</i></sub> significantly decreases and delays the peak of the sound-evoked CAPs of SGN fibers. by Maral Budak (6680351)

    Published 2021
    “…<p>(A) Sound-evoked CAPs of SGN fiber populations of varying heminode length <i>L</i><sub><i>h</i></sub> at 70dB SPL, averaged over 50 simulations. …”
  3. 1123

    Simultaneous ablation of Syt1 and Syt7 decreases the RRP size at inhibitory synapses: Rescue by WT but not mutant Syt1 or Syt7. by Taulant Bacaj (803415)

    Published 2015
    “…Recordings were performed in the presence of 1 μM tetrodotoxin, 20 μM CNQX, and 50 μM AP5 to isolate inhibitory currents. <b>B.</b> Simultaneous ablation of Syt1 and Syt7 decreases the RRP size of inhibitory synapses in a manner that is rescued by WT Syt7 (Syt1<sup>WT</sup>) but not Syt7 with mutations in the top C2 domain sequences containing the Syt7 Ca<sup>2+</sup> binding sites (Syt7<sup>C2A</sup>*<sup>B</sup>*). …”
  4. 1124
  5. 1125

    Longer <i>L</i><sub><i>u</i></sub> significantly decreases and delays the peak of the sound-evoked CAPs of SGN fibers. by Maral Budak (6680351)

    Published 2021
    “…<p>(A) Sound-evoked CAPs of SGN fiber populations with varying unmyelinated segment length <i>L</i><sub><i>u</i></sub> at 70dB SPL, averaged over 50 simulations. …”
  6. 1126
  7. 1127

    DataSheet_1_Decreased TCF1 and BCL11B expression predicts poor prognosis for patients with chronic lymphocytic leukemia.docx by Taotao Liang (9944552)

    Published 2022
    “…<p>T cell immune dysfunction is a prominent characteristic of chronic lymphocytic leukemia (CLL) and the main cause of failure for immunotherapy and multi-drug resistance. …”
  8. 1128
  9. 1129

    Decreased α-cell mass and early structural alterations of the exocrine pancreas in patients with type 1 diabetes: An analysis based on the nPOD repository by Fidéline Bonnet-Serrano (4782546)

    Published 2018
    “…Results were expressed as mean ±SD.</p><p>Results</p><p>An automated quantification method was set up using the R software and was validated by quantification of β-cell mass, a well characterized parameter. β-cell mass was 29.6±112 mg in patients and 628 ±717 mg in controls (p<0.0001). α-cell mass was 181±176 mg in patients and 349 ±241mg in controls (p<0.0001). …”
  10. 1130
  11. 1131
  12. 1132
  13. 1133
  14. 1134
  15. 1135
  16. 1136
  17. 1137

    MiR-129-5p levels were decreased in mouse depression models. by Qiaozhen Qin (13159201)

    Published 2025
    “…</b> Relative expression of miR-129-5p in the control and CRS groups. <b>M.</b> Relative expression of miR-129-5p in the CTX, HIP, and HB of control and CRS mice. …”
  18. 1138
  19. 1139
  20. 1140